Policy

BIO advocates for laws, funding and other governmental actions that ensure that biotechnology companies are able to focus on their research to drive the future of innovation.

Press Releases

BIO Statement on Senate Reintroduction of the PASTEUR Act

June 24, 2026

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the reintroduction of the bipartisan Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act in the Senate:“Moving the PASTEUR Act…

BIO International Convention Returns to San Diego to Celebrate Five Decades of Biotechnology

June 22, 2026

20,000+ biotech leaders gather with a shared mission: to improve lives SAN DIEGO (June 22, 2026) - The BIO International Convention (BIO 2026), the world’s largest and most comprehensive event for the biotechnology industry, begins today in San Diego. The convention brings together 20…

BIO Statement on Veto of Prescription Drug Affordability Boards (PDAB) in Virginia

May 22, 2026

Patrick J. Plues, Senior Vice President of State Government Affairs & Affiliate Relations at the Biotechnology Innovation Organization (BIO) released the following statement on the veto of Prescription Drug Affordability Boards (PDAB) legislation in Virginia:“BIO applauds Governor Spanberger’s…